Emgality
Chemical Name | galcanezumab-gnlm |
Dosage Form | Injection (subcutaneous; 120 mg, 300 mg) |
Drug Class | Monoclonal antibodies |
System | Nervous |
Company | Eli Lilly and Company |
Approval Year | 2018 |
Indication
- The prevention of migraines in adults.
Chemical Name | galcanezumab-gnlm |
Dosage Form | Injection (subcutaneous; 120 mg, 300 mg) |
Drug Class | Monoclonal antibodies |
System | Nervous |
Company | Eli Lilly and Company |
Approval Year | 2018 |